A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 23,288 shares of RDY stock, worth $357,936. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,288
Previous 23,288 -0.0%
Holding current value
$357,936
Previous $1.77 Million 4.28%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$67.36 - $77.59 $19,669 - $22,656
292 Added 1.27%
23,288 $1.71 Million
Q2 2023

Aug 08, 2023

BUY
$53.34 - $63.11 $476,539 - $563,824
8,934 Added 63.53%
22,996 $1.45 Million
Q4 2021

Feb 09, 2022

BUY
$59.5 - $67.25 $116,917 - $132,146
1,965 Added 16.24%
14,062 $920,000
Q3 2021

Nov 08, 2021

BUY
$60.19 - $75.29 $218,670 - $273,528
3,633 Added 42.92%
12,097 $788,000
Q4 2019

Feb 11, 2020

SELL
$36.66 - $41.78 $16,643 - $18,968
-454 Reduced 5.09%
8,464 $343,000
Q3 2019

Nov 12, 2019

SELL
$34.82 - $39.26 $16,609 - $18,727
-477 Reduced 5.08%
8,918 $338,000
Q2 2019

Aug 02, 2019

SELL
$36.05 - $42.76 $326,360 - $387,106
-9,053 Reduced 49.07%
9,395 $352,000
Q1 2019

Apr 26, 2019

SELL
$35.77 - $40.57 $623,220 - $706,851
-17,423 Reduced 48.57%
18,448 $747,000
Q4 2018

Feb 13, 2019

BUY
$31.89 - $38.44 $350,630 - $422,647
10,995 Added 44.2%
35,871 $1.35 Million
Q2 2018

Aug 01, 2018

SELL
$28.49 - $35.06 $1.1 Million - $1.35 Million
-38,536 Reduced 60.77%
24,876 $801,000
Q1 2018

May 07, 2018

BUY
$31.93 - $39.54 $1.11 Million - $1.37 Million
34,608 Added 120.15%
63,412 $2.07 Million
Q3 2017

Nov 02, 2017

BUY
$30.11 - $37.72 $867,288 - $1.09 Million
28,804
28,804 $1.03 Million

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.55B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Bnp Paribas Asset Management Holding S.A. Portfolio

Follow Bnp Paribas Asset Management Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.